515 related articles for article (PubMed ID: 30254404)
1. Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma.
Rastogi A
World J Gastroenterol; 2018 Sep; 24(35):4000-4013. PubMed ID: 30254404
[TBL] [Abstract][Full Text] [Related]
2. Role of liver biopsy in hepatocellular carcinoma.
Di Tommaso L; Spadaccini M; Donadon M; Personeni N; Elamin A; Aghemo A; Lleo A
World J Gastroenterol; 2019 Oct; 25(40):6041-6052. PubMed ID: 31686761
[TBL] [Abstract][Full Text] [Related]
3. Update on Hepatocellular Carcinoma: a Brief Review from Pathologist Standpoint.
Karadag Soylu N
J Gastrointest Cancer; 2020 Dec; 51(4):1176-1186. PubMed ID: 32844348
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic histopathology of hepatocellular carcinoma: A case-based review.
Agni RM
Semin Diagn Pathol; 2017 Mar; 34(2):126-137. PubMed ID: 28143798
[TBL] [Abstract][Full Text] [Related]
5. When and how should we perform a biopsy for HCC in patients with liver cirrhosis in 2018? A review.
Russo FP; Imondi A; Lynch EN; Farinati F
Dig Liver Dis; 2018 Jul; 50(7):640-646. PubMed ID: 29636240
[TBL] [Abstract][Full Text] [Related]
6. Methylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomy.
Sun FK; Sun Q; Fan YC; Gao S; Zhao J; Li F; Jia YB; Liu C; Wang LY; Li XY; Ji XF; Wang K
J Gastroenterol Hepatol; 2016 Feb; 31(2):484-92. PubMed ID: 26313014
[TBL] [Abstract][Full Text] [Related]
7. [Hepatocellular carcinoma].
Semela D; Heim M
Ther Umsch; 2011 Apr; 68(4):213-7. PubMed ID: 21452143
[TBL] [Abstract][Full Text] [Related]
8. Update on hepatocellular carcinoma: Pathologists' review.
El Jabbour T; Lagana SM; Lee H
World J Gastroenterol; 2019 Apr; 25(14):1653-1665. PubMed ID: 31011252
[TBL] [Abstract][Full Text] [Related]
9. Current management of hepatocellular carcinoma.
Mendizabal M; Reddy KR
Med Clin North Am; 2009 Jul; 93(4):885-900, viii. PubMed ID: 19577120
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers for hepatocellular carcinoma: What's new on the horizon?
Ocker M
World J Gastroenterol; 2018 Sep; 24(35):3974-3979. PubMed ID: 30254402
[TBL] [Abstract][Full Text] [Related]
11. Report from European Association for the Study of the Liver: HCC Summit, Geneva, Switzerland, 2-5 February 2017.
Sacco R; Mirabile A; Giacomelli L; Bresci G; Attardo S; Cabibbo G
Future Oncol; 2017 Jun; 13(15):1297-1300. PubMed ID: 28589772
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and outcomes of patients with hepatocellular carcinoma in non-cirrhotic liver.
Wörns MA; Bosslet T; Victor A; Koch S; Hoppe-Lotichius M; Heise M; Hansen T; Pitton MB; Niederle IM; Schuchmann M; Weinmann A; Düber C; Galle PR; Otto G
Scand J Gastroenterol; 2012 Jun; 47(6):718-28. PubMed ID: 22472070
[TBL] [Abstract][Full Text] [Related]
13. Role of biopsy sampling for diagnosis of early and progressed hepatocellular carcinoma.
Kim H; Park YN
Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):813-29. PubMed ID: 25260310
[TBL] [Abstract][Full Text] [Related]
14. Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective.
Colombo M; Raoul JL; Lencioni R; Galle PR; Zucman-Rossi J; Bañares R; Seehofer D; Neuhaus P; Johnson P
Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):639-51. PubMed ID: 23628963
[TBL] [Abstract][Full Text] [Related]
15. Systemic therapies for hepatocellular carcinoma.
Ge S; Huang D
Drug Discov Ther; 2015 Oct; 9(5):352-62. PubMed ID: 26632544
[TBL] [Abstract][Full Text] [Related]
16. Pediatric hepatocellular carcinoma.
Khanna R; Verma SK
World J Gastroenterol; 2018 Sep; 24(35):3980-3999. PubMed ID: 30254403
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for hepatocellular carcinoma.
Li S; Yang F; Ren X
Drug Discov Ther; 2015 Oct; 9(5):363-71. PubMed ID: 26632545
[TBL] [Abstract][Full Text] [Related]
18. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.
Okajima W; Komatsu S; Ichikawa D; Miyamae M; Ohashi T; Imamura T; Kiuchi J; Nishibeppu K; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
World J Gastroenterol; 2017 Aug; 23(31):5650-5668. PubMed ID: 28883691
[TBL] [Abstract][Full Text] [Related]
19. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.
Ha SY; Kim JH; Yang JW; Kim J; Kim B; Park CK
Cancer Res Treat; 2016 Jul; 48(3):1065-73. PubMed ID: 26511806
[TBL] [Abstract][Full Text] [Related]
20. Natural history and treatment trends in hepatocellular carcinoma subtypes: Insights from a national cancer registry.
Jernigan PL; Wima K; Hanseman DJ; Hoehn RS; Ahmad SA; Shah SA; Abbott DE
J Surg Oncol; 2015 Dec; 112(8):872-6. PubMed ID: 26603598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
